DAXOR CORP
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- 2.54%
About Daxor
Daxor Corporation is a medical device manufacturing company that also offers biotechnology services. Its core focus centers on the creation, manufacturing, and development of the BVA-100 Blood Volume Analyzer, an instrument designed to measure human blood volume rapidly and precisely. The analyzer operates alongside Volumex, a proprietary single-use radiopharmaceutical diagnostic injection and collection kit. Through its subsidiary Scientific Medical Systems and Idant, the company also provides cryobanking services for blood and semen storage. The firm's products primarily serve hospitals, radiology imaging centers, critical care units, and specialized medical clinics.
The company operates its research, development, and manufacturing operations from the Daxor Oak Ridge Operations facility across two ten thousand square foot buildings in Oak Ridge, Tennessee. Its customer market consists of domestic medical centers across the United States as well as potential international users. Daxor Corporation maintains its principal executive offices in New York, New York.
Summary of the business section of Daxor's latest annual report, written by StockData.
Company profile
Company
- Legal name
- DAXOR CORP
- Founded
- 1971
- Headquarters
- Oak Ridge, TN
- Address
- 107 Meco Lane 37830
- Phone
- (865) 425-0555
- Website
- daxor.com
- Employees
- 35, Dec 31, 2003
- Incorporated in
- New York
- Fiscal year ends
- December 31
Stock & identifiers
- Ticker
- DXR
- Exchange
- Nasdaq
- IPO date
- Jul 25, 1983
- Shares outstanding
- 4M, Mar 22, 2012
- Public float
- $10.06M, Jun 30, 2011
- SEC CIK
- 27367
- CUSIP
- 239467103
- ISIN
- US2394671034
- LEI
- 984500B839ED8XIK6792
- EIN
- 13-2682108
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Michael Richard Feldschuh | Chief Executive Officer, Director | 243,694 |
| Jonathan Adam Feldschuh | Chief Scientific Officer, Director | 78,908 |
| John Jefferies | Chief Medical Officer | 26,008 |
| Robert J. Michel | Chief Financial Officer | 33,050 |
| Caleb DesRosiers | Director | 3,157 |
| Edward Feuer | Director | 1,000 |
| Joy S. Goudie | Director | 300 |
| Henry D. Cremisi | Director | – |
Employees
Headcount reported in annual reports
“On March 24, 2004, the Company had 35 employees.”
Corporate history
Events identified from SEC filings